Results 121 to 130 of about 16,725 (189)

Multicellular senescence programs in the aged heart. [PDF]

J Mol Cell Cardiol Plus
Bultot L, Tsurudome N, Kumazaki E, Shimizu I.   +3 more
europepmc   +1 more source

Therapeutic advances in HR+/HER2- advanced breast cancer after failure of CDK4/6 inhibitor therapy. [PDF]

Front Oncol
Cui M, Xiao J, Ma L, Liang Y, Liang J.
europepmc   +1 more source

Transmembrane BAX inhibitor motif containing 1 inhibition of lysosomal degradation of TGF-β receptor 1 suppresses cellular senescence and hepatocarcinogenesis. [PDF]

J Biol Chem
Zhou D, Yu W, Zheng Y, Hou X, Zhang K, Qian X, Duan L, Feng S, Xue M, Zhu X, Zhang H, Zhang L, Wei L, Liu W, Jiang J, Zhang L.   +15 more
europepmc   +1 more source

CMGC Kinases in Viral Infection and Human Disease. [PDF]

Pathogens
Amusan OT, Guo H.
europepmc   +1 more source

Cell Type-Specific Expression of p16, p21, and p53 Reveals Age-Dependent Glial Senescence in the App^NL-G-F Mouse Model of Alzheimer's Disease. [PDF]

Aging Cell
Sweeney EM, Abate G, Bakker BRV, Mastinu A, Lai Y, Uberti D, Nilsson P, Tambaro S.   +7 more
europepmc   +1 more source

Cellular Senescence: Emerging Therapeutic Target for Idiopathic Pulmonary Fibrosis Pathogenic Mechanisms and Therapeutic Strategies. [PDF]

Biomol Ther (Seoul)
Suwanprakorn N, Choi Y, Choi YS, Yoo HJ, Yang SG.   +4 more
europepmc   +1 more source

A Review of Ionizing Radiation-Induced Senescence of Bone Marrow Mesenchymal Stem/Stromal Cells: Mechanisms and Therapeutic Strategies. [PDF]

Curr Issues Mol Biol
Li X, Chen M, Zhang Y, Li J, Xiang L, Xiao Y, Xiang Y, Chen L, Ran Q, Li Z.   +9 more
europepmc   +1 more source

PLGA Nanoparticle-Mediated Sustained Release of Fisetin for Intra-Articular Therapy of Temporomandibular Joint Osteoarthritis. [PDF]

Int J Mol Sci
Zhang M, Jo JI, Hashimoto Y, Honda Y, Nishiura A.   +4 more
europepmc   +1 more source

Senolytics, dasatanib plus quercetin, reduce kidney inflammation, senescent cell abundance, and injury while restoring geroprotective factors in murine diabetic kidney disease. [PDF]

EBioMedicine
Bian X, Snow ZK, Zinn CJ, Bratulin AL, Elhusseiny KM, Tchkonia T, Kirkland JL, Zhu Y, Khosla S, Kim SR, Lerman LO, Hickson LJ.   +11 more
europepmc   +1 more source

[Corrigendum] CDKN2A (p16INK4A) affects the anti‑tumor effect of CDK inhibitor in somatotroph adenomas [PDF]

Int J Mol Med
Chen Y, Li Z, Fang Q, Wang H, Li C, Gao H, Zhang Y.   +6 more
europepmc   +1 more source